Inclusive
Innovation
and
Healthcare
Meeting opening
Presidents address
Disclaimer: The views expressed in this paper/presentation are the views of the author and do
not necessarily reflect the views or policies of the Asian Development Bank (ADB), or its Board
of Governors, or the governments they represent. ADB does not guarantee the accuracy of the
data included in this paper and accepts no responsibility for any consequence of their use.
Terminology used may not necessarily be consistent with ADB official terms.
Who we are
The Global Research
Alliance (GRA) is:
a collaboration of eight
of the worlds leading
applied-research
agencies
using the best science
and technology
working to solve some
of the biggest
challenges in the
developing world
What we do
The GRAs vision is for a world where the
application of innovative science and technology,
through collaboration and co-creation, delivers
access equality, improves lives and solves global
development challenges.
Our focus
global research for global good
Health
Food
ICT
Water
Energy
Inclusive Innovation
access equality despite income inequality
We aspire to build:
Self-reliance
Economic benefits
Social inclusion
Defining the
need and
relevance
by ..
Mobilising
the best
team
Partnering
for impact
Making a
difference
Innovative devices
Open discovery
Agriculture/Aquaculture
Information/Communication Technology
$28 Foot
And
$20 Knee
BLISS4Midwives
Improving maternal health in rural Africa
TNO, Netherlands
Non-invasive
Hb
Anemia
Awareness
User
instructions
Urine strips
- Glucose
- Protein
Gestational
Diabetes
Nutrition
Referrals
Therapy
Commcare
cloud
Blood pressure
BLISS4Midwives
4 May 2015
Preeclampsia
of
Pathogens
Micro PCR
Rapid detection of Hepatitis-B Virus
Targeted for deployment at Rural health
care centres and designed for use by
minimally skilled personnel
Argemone Mexicana is a
plant that contains many
alkaloids.
Use clinical experiences and
qualitative experiences to
develop treatment
candidates
No affect on animals,
therefore animal testing
would have been
inconclusive.
Subjects treated and tested
for malaria-causing
parasites in their blood
Substantial decrease seen
over 7 days
Candidate
Targets
Lead
Molecules
in silico SCREENING
Mycobacterium tuberculosis
PRECLINICAL &
CLINICAL TRIAL
in vivo VALIDATION
Wiki Portal
Academia
& Hospitals
Exchange of Ideas/Results
Community Participation
Lead Organization
Council of Scientific and
Industrial Research (CSIR), India
Current Partners
Contract
Research
Organisations
Drug
Technology transfer
Capacity building
Country specific analyses
Program design and management
Meeting opening
Presidents address
Thank you
Gerald Hane
Battelle Memorial Institute
haneg@battelle.org